Chesley Taft & Associates LLC Medtronic PLC Transaction History

Chesley Taft & Associates LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 05, 2022	SELL	$99.53 - $127.75 $292,717 - $375,712	-2,941 Closed	0 $0
Q3 2021 Oct 05, 2021	BUY	$122.75 - $135.17 $2,823 - $3,108	23 Added 0.79%	2,941 $369,000
Q2 2021 Jul 07, 2021	BUY	$118.19 - $131.5 $47,276 - $52,600	400 Added 15.89%	2,918 $362,000
Q1 2021 Apr 06, 2021	BUY	$111.18 - $119.74 $8,672 - $9,339	78 Added 3.2%	2,518 $303,000
Q4 2020 Jan 11, 2021	BUY	$100.57 - $117.14 $301 - $351	3 Added 0.12%	2,440 $286,000
Q2 2020 Jul 08, 2020	BUY	$84.11 - $103.33 $204,976 - $251,815	2,437 New	2,437 $223,000
Q1 2020 Apr 15, 2020	SELL	$72.92 - $121.3 $133,370 - $221,857	-1,829 Closed	0 $0
Q4 2019 Jan 10, 2020	BUY	$104.49 - $114.54 $191,112 - $209,493	1,829 New	1,829 $208,000
Q2 2019 Jul 10, 2019	SELL	$84.15 - $99.38 $843,940 - $996,682	-10,029 Closed	0 $0
Q1 2019 Apr 05, 2019	BUY	$82.45 - $93.79 $86,572 - $98,479	1,050 Added 11.69%	10,029 $913,000
Q4 2018 Jan 07, 2019	BUY	$85.8 - $99.49 $770,398 - $893,320	8,979 New	8,979 $817,000

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $113B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Chesley Taft & Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Chesley Taft & Associates LLC with notifications on news.